Thrombin Upregulates PAI-1 and Mesothelial–Mesenchymal Transition Through PAR-1 and Contributes to Tuberculous Pleural Fibrosis

Autor: Cheng Ying Hsieh, Joen Rong Sheu, Wei Lin Chen, Chih Hao Yang, Jie Heng Tsai, Chi Li Chung
Jazyk: angličtina
Rok vydání: 2019
Předmět:
0301 basic medicine
Male
Mesoderm
lcsh:Chemistry
chemistry.chemical_compound
Mice
Phosphatidylinositol 3-Kinases
0302 clinical medicine
lcsh:QH301-705.5
Spectroscopy
Aged
80 and over

mesothelial–mesenchymal transition
biology
General Medicine
Exudates and Transudates
Middle Aged
respiratory system
thrombin
Computer Science Applications
Effusion
Plasminogen activator inhibitor-1
Pleura
plasminogen activator inhibitor-1
Female
pleural fibrosis
residual pleura thickening
medicine.drug
Signal Transduction
Adult
tuberculous pleural fibrosis
Catalysis
Article
Inorganic Chemistry
03 medical and health sciences
Tissue factor
Young Adult
Thrombin
In vivo
Plasminogen Activator Inhibitor 1
medicine
Animals
Humans
Tuberculosis
Receptor
PAR-1

Physical and Theoretical Chemistry
tuberculous pleural effusion
Molecular Biology
Aged
business.industry
Organic Chemistry
Mycobacterium tuberculosis
Fibrosis
In vitro
respiratory tract diseases
Fibronectin
Mice
Inbred C57BL

Pleural Effusion
Disease Models
Animal

pleural mesothelial cell
030104 developmental biology
030228 respiratory system
chemistry
lcsh:Biology (General)
lcsh:QD1-999
biology.protein
Cancer research
business
Plasminogen activator
Follow-Up Studies
Zdroj: International Journal of Molecular Sciences, Vol 20, Iss 20, p 5076 (2019)
International Journal of Molecular Sciences
Volume 20
Issue 20
ISSN: 1422-0067
Popis: Thrombin is an essential procoagulant and profibrotic mediator. However, its implication in tuberculous pleural effusion (TBPE) remains unknown. The effusion thrombin and plasminogen activator inhibitor-1 (PAI-1) levels were measured among transudative pleural effusion (TPE, n = 22) and TBPE (n = 24) patients. Pleural fibrosis, identified as radiological residual pleural thickening (RPT) and shadowing, was measured at 12-month follow-up. Moreover, in vivo and in vitro effects of thrombin on PAI-1 expression and mesothelial&ndash
mesenchymal transition (MMT) were assessed. We demonstrated the effusion thrombin levels were significantly higher in TBPE than TPE, especially greater in TBPE patients with RPT >
10mm than those without, and correlated positively with PAI-1 and pleural fibrosis area. In carbon black/bleomycin-treated mice, knockdown of protease-activated receptor-1 (PAR-1) markedly downregulated &alpha
smooth muscle actin (&alpha
SMA) and fibronectin, and attenuated pleural fibrosis. In pleural mesothelial cells (PMCs), thrombin concentration-dependently increased PAI-1, &alpha
SMA, and collagen I expression. Specifically, Mycobacterium tuberculosis H37Ra (MTBRa) induced thrombin production by PMCs via upregulating tissue factor and prothrombin, and PAR-1 silencing considerably abrogated MTBRa&minus
stimulated PAI-1 expression and MMT. Consistently, prothrombin/PAR-1 expression was evident in the pleural mesothelium of TBPE patients. Conclusively, thrombin upregulates PAI-1 and MMT and may contribute to tuberculous pleural fibrosis. Thrombin/PAR-1 inhibition may confer potential therapy for pleural fibrosis.
Databáze: OpenAIRE
Nepřihlášeným uživatelům se plný text nezobrazuje